Interestingly, ATP1B1 expression levels were also decreased after TMAO treatment (Figure 5B, C), suggesting that ATP1B1 may be involved in the regulation of TMAO on endothelial cell function to attenuate liver fibrosis. The gene discussed is ATP1B1; the disease is Hepatic fibrosis.